1.
Duszak R,
Jr,
Parker L,
Levin DC,
Rao VM.
Placement and removal of inferior vena cava filters: national trends in the medicare population.
J Am Coll Radiol.
2011;8:483–489.
doi: 10.1016/j.jacr.2010.12.021.
2.
Friedell ML,
Nelson PR,
Cheatham ML.
Vena cava filter practices of a regional vascular surgery society.
Ann Vasc Surg.
2012 Jul;26(5):630-5.
doi: 10.1016/j.avsg.2011.11.033.
3.PREPIC Study Group.
Decousus H,
Buchmuller-Cordier A,
Carbonnier B,
Girard P,
Lamer C,
Laporte S,
Leizorovicz A,
Mismietti P,
Parent F,
Quenet S,
Rivron-Guillot K,
Tardy B.
Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study.
Circulation.
2005;112:416–422.
doi: 10.1161/CIRCULATIONAHA.104.512834.
4.
Mismetti P,
Laporte S,
Pellerin O,
et al.
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial.
JAMA.
2015;313:1627–1635.
doi: 10.1001/jama.2015.3780.
5.
Administration USFaD.
Removing retrievable inferior vena cava filters: FDA Safety Communication.
2014.
6.
Morales JP,
Li X,
Irony TZ,
Ibrahim NG,
Moynahan M,
Cavanaugh Jr KJ.
Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism.
J Vasc Surg: Venous Lymphatic Disord.
2013;1:376–84.
7.
Antithrombotic Therapy for VTE Disease Kearon,
Clive et al.
Chest.
2016 Feb;149(2):315-352.
doi: 10.1016/j.chest.2015.11.026.
Epub 2016 Jan 7.